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ABSTRACT 
Despite being a GOLD guideline and having documented benefits, confirming a COPD 
diagnosis with spirometry is not routinely done.  The purpose of this project was to increase 
patient referrals for spirometry to confirm COPD diagnosis.  A quasi-experimental design was 
incorporated in a primary care office.  A retrospective pre-intervention chart audit and two post-
chart audits, 30-days apart, compared the frequency of documented spirometry to confirm a 
COPD diagnosis.  An educational intervention with a pre and post-survey examined provider 
behavior intention to order spirometry to confirm a COPD diagnosis.  The pre-chart audit 
revealed that 27/50 (54%) of patients had spirometry documented to confirm a COPD diagnosis.  
Thirty-day post chart audit and feedback intervention revealed 33/50 (66%) and sixty-day post 
chart audit and feedback intervention revealed 31/50 (62%) of patients had spirometry 
documented to confirm a COPD diagnosis.  The Z-test at 30 days revealed the P-value 
corresponding to z-1.225 is 0.112.  The Z-test from the pre-chart audit to the 60-day post-chart 
audit revealed the P-value corresponding to z-0.8104 is 0.2088.  The post-survey of 6 providers 
revealed a behavior intention increase from 63.4% to 86.6%, a 23.3% increase in behavior 
intention.  Although there was not a statistically significant increase in the number of spirometry 
referrals, there was a clinically significant increase.  After implementing a chart audit and 
educational intervention, the provider’s behavior intention also increased.  Hence, a chart audit 
and educational intervention may be helpful to improve primary care provider’s behavior 
intention for specific clinical practice guidelines. 
 Keywords: Spirometry, COPD, primary care, chart audit. 
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Introduction 
Chronic obstructive pulmonary disease (COPD) is a common, progressive, and 
debilitating disease that affects many people worldwide on a daily basis.  COPD is characterized 
by an airway chronic inflammatory reaction from factors such as respiratory gases, especially 
tobacco smoke (Ghattas et al., 2013).  COPD is prevalent and imposes a major fiscal burden on 
our global healthcare system.  In 2010, COPD incurred approximately $50 billion from direct 
and indirect expenses (Guarascio, Ray, Finch, & Self, 2013).  COPD affects approximately 6.3% 
of people in the United States, or 15 million adults (CDC, 2012).  Current practice 
recommendations by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 
guidelines identify the significance of confirming a COPD diagnosis using spirometry (GOLD, 
2017).  Use of spirometry helps avoid misdiagnoses, determine prognosis, and guide treatment 
(GOLD, 2017).  Healthcare providers have a weighty responsibility to properly diagnose and 
treat patients and must strongly consider the recommendations by reputable sources such as the 
GOLD standards (GOLD, 2017). 
Spirometry is an objective, readily available, and noninvasive method to confirm the 
diagnosis of COPD (GOLD, 2017).  Utilizing spirometry aids in avoiding misdiagnosing COPD, 
indirectly reduces COPD readmissions, improves patient outcomes and safety concerns, 
improves quality of life, is fiscally beneficial, and may ultimately reduce the global burden 
COPD has on the health care system.  Chart audit and performance feedback is an efficient 
method to improve provider’s compliance with evidenced-based practice guidelines, such as the 
usage of spirometry to confirm COPD diagnosis (Ivers et al., 2013).  The purpose of this project 
is to determine the effectiveness of using a chart audit and feedback method to educate primary 
care providers on confirming COPD diagnosis with spirometry. 
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Background 
Epidemiology of COPD 
COPD is a common disease, characterized by its chronic and progressive nature.  It is a 
major cause of morbidity and mortality around the world.  It is the fourth leading cause of 
mortality, and by 2020 is suspected to increase to the third main cause of death (GOLD, 2017).  
The prevalence of COPD still continues to be high in the United States.  Approximately 6.3% of 
people in the United States, or 15 million adults suffer from COPD (CDC, 2012).  COPD also 
impacts morbidity and is associated with many co-morbid conditions.  A large cross-sectional 
study examined COPD and its co-morbidities in the primary care setting.  These co-morbidities 
include anxiety, depression, hypertension, and many others (Chetty et al., 2017).  This study 
concluded that patients with COPD are much more likely to have many physical and mental co-
morbidities that coincide with this disease than those who do not have COPD (Chetty et al., 
2017).  Within the fiscal perspective, COPD causes a large burden on the global healthcare 
system.  In 2010, the amount of both direct and indirect expenses that COPD incurred summated 
approximately $50 billion (Guarascio et al., 2013). 
COPD Diagnosis 
Providers have a responsibility to correctly diagnose and treat their patients to prevent 
long-term complications and to delay the progression of a disease (Wood, 2014).  Since COPD is 
chronic and progressive, the earlier that an accurate diagnosis is made, the better the outcome 
(Wood, 2014).  In order to understand the importance of spirometry, COPD in general needs to 
be briefly examined regarding risk factors, etiology, diagnosis, and clinical manifestations. 
Tobacco smoke is the most common identified risk factor for developing COPD (GOLD, 
2017).  Other risk factors include being exposed to occupational and other air pollutants.  
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Although nonsmokers can also develop COPD, the pathophysiology behind COPD involves a 
conglomeration of exposure to harmful gases and specific host susceptibilities.  These specific 
host considerations include genetic components, asthma, history of pulmonary infections, 
advanced age, female gender, and lower socioeconomic status (GOLD, 2017). 
Signs and symptoms of COPD include chronic dyspnea, cough, and sputum production 
(GOLD, 2017).   The dyspnea is considered progressive in nature, is often exacerbated with 
exercise, and persists (GOLD, 2017).  A chronic cough of someone with COPD may be either 
productive or non-productive in nature (GOLD, 2017).  A patient who is suspected to have 
COPD based on their symptoms of the chronic cough, dyspnea, and/or sputum production with 
known risk factors are good candidates for spirometry evaluation to confirm the COPD diagnosis 
(GOLD, 2017). 
Spirometry, is considered the gold standard for diagnosing COPD (GOLD, 2017).  
Spirometry is non-invasive and measures many aspects of one’s pulmonary capabilities 
including capacity, lung volume, the rate of flow, and gas exchange, which helps the provider in 
differentiating between multiple differential diagnoses (John Hopkins Medicine, n.d).  
Spirometry specifically differentiates between an obstructive and a restrictive breathing pattern 
based on the results of the testing (John Hopkins, n.d.).  Spirometry measures various values to 
determine these results including tidal volume, total lung capacity, forced vital capacity (FVC), 
and forced expiratory volume (FEV), with the last two being most important to the diagnosis of 
COPD (John Hopkins Medicine, n.d.).  Spirometry is considered the gold standard for several 
reasons including its non-invasive characteristics, feasibility, that it is readily available, highly 
sensitive, reproducible, and objective (GOLD, 2017).  Therefore, the 2017 guidelines identify 
spirometry as essential in diagnosing COPD (GOLD, 2017). 
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The cost of spirometry needs to be examined if it is recommended that primary care 
providers should order them.  According to the Centers for Medicare and Medicaid (CMS), 
insurance coverage for spirometry will be provided if it is generally indicated (CMS, n.d.).  
These indications include documentation that supports signs, symptoms, abnormal laboratory 
testing, examination for preoperative risks, the patient’s prognosis, and/or the impact specific 
diseases have on their pulmonary system (CMS, n.d.). 
Spirometry usage benefits. Utilizing spirometry to confirm the diagnosis of COPD in 
the primary care setting has many documented benefits.  Some of these benefits include 
spirometry assistance in avoiding misdiagnosing COPD, cost saving approaches, and reducing 
the considerable burden COPD has on the healthcare system (Walters et al., 2011 & Fortis et al., 
2016).  It also helps prevent COPD readmissions and improve the patient’s quality of 
life/outcomes (Guerriero et al., 2015). 
Despite all of the recommendations and positive characteristics, spirometry is still widely 
underutilized in diagnosing COPD.  This results in patients often being misdiagnosed with 
COPD (Walters et al., 2011).  In 2011, a cross-sectional study examined 341 patients in Australia 
who were diagnosed with COPD (Walters et al., 2011). The 341 patients in the study were 
examined using spirometry and the results identified 107 of those patients (31%), who did not 
have COPD even though they were diagnosed based on their symptoms and had been prescribed 
several inhalers (Walters et al., 2017).  The study concluded that diagnosing COPD solely on 
symptoms is unreliable in the primary care setting and that these patients need spirometry to 
confirm their COPD diagnoses (Walters et al., 2017). 
Incorrectly diagnosing a patient with COPD also impacts patient safety, results in 
financial waste, and burdens the global healthcare system.  A longitudinal population study that 
SPIROMETRY AND COPD DIAGNOSIS   
 
15
was conducted from 2005 to 2012 in Canada examined charts from patients who had been 
diagnosed with COPD.  The article identified 68,898 patients with COPD and noted that only 
41.2% of these patients received spirometry (Gershon et al., 2017).  The analyses concluded 
those COPD patients who received spirometry were 9% less likely to be admitted to the hospital 
for a COPD cause, or die for any reason, than those patients with COPD who did not have 
spirometry completed (Gershon et al., 2017).  Therefore, it appears that the number of primary 
care patients who receive spirometry prior to their COPD diagnosis needs to be increased in 
order to reduce morbidity and mortality as well as improve patient safety. 
Spirometry also assists the provider in properly determining the severity of the patient’s 
COPD.  Without completing spirometry, the provider is likely to underestimate the severity of 
their patient’s COPD (Mapel, Dalal, Johnson, Becker, & Hunter, 2015).  A multicultural, cross-
sectional, observational study in the United States examined 899 patients who had COPD and 
their providers, in order to determine whether the provider’s impressions of the severity of their 
patients changed before and after spirometry (Mapel et al., 2015).  Disease severity was realized 
to be more severe than what had been thought in 17% and less severe in 5% of the patients after 
spirometry testing resulted (p<0.05).  Also, the treatment for about one-third of these patients 
changed after they received spirometry since the understanding of their severity had also 
changed (Mapel et al., 2105).  Therefore, spirometry is important not only to diagnose COPD, 
but also to assist in treatment to improve patient safety and subsequently reduce costs. 
COPD is a very common disease that impacts not only morbidity and mortality, but also 
has significant effects on reimbursement rates and hospital readmissions in the United States 
(U.S.).  In 2010, the amount of both direct and indirect expenses that COPD incurred summated 
approximately $50 billion (Guarascio et al., 2013).  COPD is also a common cause of 
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preventable readmissions to the hospital in the United States (U.S. Department of Health and 
Human Services, 2015).  If a higher number of patients with COPD was accurately diagnosed 
with spirometry, then the number of inaccurately diagnosed “COPD” readmissions would be 
indirectly decreased (Spero et al., 2017).  The U.S. Centers for Medicare and Medicaid (CMS) 
has imposed financial disincentives to hospitals with an “unacceptably” high COPD readmission 
rate (CMS, n.d.).  Therefore, spirometry may potentially save local hospitals monetary revenue 
in COPD reimbursement rates. 
Chart audit and Provider Feedback 
 The purpose of a chart audit is to identify whether certain factors can be improved upon.  
Provider feedback refers to giving guidance to the provider on ways to improve the area being 
audited.  Evidence within the literature identifies the chart audit and feedback method as 
successful in improving healthcare provider performance measures with compliance to 
guidelines (Ivers et al., 2012).  One such manuscript by Ospina et al., 2017 intended to review 
the success of COPD discharge care bundles, in which documenting spirometry was a 
component.  The chart audit and feedback method was one strategy utilized, which ultimately 
resulted in reduced readmission rates (Ospina et al., 2017).  In a chart audit and provider 
feedback study, McClellan et al (2003) identified that a chart feedback and education method 
regarding A1C levels resulted in improved treatment for diabetic Medicare patients.  This chart 
audit and feedback method was similarly utilized to educate primary care providers on the need 
for spirometry to confirm a COPD diagnosis.  Hence, a chart audit and feedback system has been 
proven through various studies to be an effective intervention to improve provider compliance 
and was used in this project to improve provider compliance with ordering spirometry. 
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Problem Statement 
Despite the 2017 GOLD guidelines and a plethora of other quality literature, 
approximately 30% of patients are misdiagnosed with COPD due to a lack of utilization of 
spirometry in the primary care setting (Walters et al., 2011).  The 2017 GOLD guidelines 
recommend utilizing spirometry to confirm the diagnosis of COPD.  Utilizing spirometry for 
COPD diagnosis has been shown to reduce COPD misdiagnoses, assist in cost saving 
approaches, reduce the considerable burden COPD has on the healthcare system, prevent COPD 
readmissions, and improve quality of life/outcomes. 
Purpose of the Project 
The purpose of this scholarly project is to implement a chart audit and feedback method 
aimed at educating primary care providers to increase the appropriate ordering of spirometry.  
Utilizing a chart audit and feedback method has been shown to be successful in improving 
healthcare provider compliance with evidenced-based practice guidelines (Ivers et al., 2012). 
Clinical Question 
 Does a chart audit and feedback method improve the number of primary care providers 
who appropriately order spirometry to confirm the diagnosis of COPD? 
Population: Primary care providers. 
Intervention: Chart audit and educational feedback. 
Comparison: Standard practice. 
Outcomes: Increase appropriate use of spirometry to confirm the COPD diagnosis. 
Literature Review and Synthesis 
 A comprehensive electronic database search was completed using ProQuest, CINAHL, 
and the Cochrane Library.  Search terms included spirometry, COPD, gold standard, providers, 
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quality of care, chart audit and feedback.  No limits were placed on the type of article or 
published date.  The search was limited to the English language with full text.  A total of 
approximately 800 articles with published dates ranging from 2001 to 2017 were identified.  
Narrowing down the search based on the quality of the literature, relevance, published date, and 
type of study, ultimately yielded 21 articles for the literature review. 
Quality Critical Appraisal 
 A single reviewer examined the quality of each study and the guidelines were appraised 
according to the Appraisal of Guidelines Research & Evaluation II tool (AGREE, 2013).  The 
systematic reviews and other clinical trials were appraised according to the Scottish 
Intercollegiate Guidelines Network (SIGN, 2015).  The team leader examined each article for the 
level of evidence according to Melnyk’s system of hierarchy (University of Michigan Library, 
2015).  The quality of each study is provided in Appendix A. 
Systematic Reviews 
 A strong systematic review of randomized controlled trials reveals the impact audit and 
feedback has on healthcare professionals practice and patient outcomes (Ivers et al., 2012).  In 
addition, the purpose of the systematic review was to examine some causes of the differences 
between the effectiveness of various audit and feedback opportunities (Ivers et al., 2012). 
 The systematic review analyzed 140 randomized controlled trials, and only trials which 
utilized the audit and feedback system as a core component of their intervention were considered 
as part of the systematic review (Ivers et al., 2012).  Two independent reviewers examined these 
trials after eliminating trials with a considerably high risk of bias, 82 comparisons from 49 
studies, and those displaying dichotomous outcomes (Ivers et al., 2012).  The weighted median 
adjusted risk difference (RD) was a 4.3% increase in healthcare providers’ compliance with an 
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interquartile range of 0.5% to 16% absolute increase after utilizing audit and feedback (Ivers et 
al., 2012).  Multivariable meta-regression determined feedback is more effective when the prior 
performance level is considered low, when the feedback was presented by a supervisor or 
colleague, when the feedback is presented more than once, if it is presented in verbal and written 
methods, and when it incorporates explicit targets and an action plan (Ivers et al., 2012).  Finally, 
the magnitude of impact was altered by the clinical behavior designed by the intervention (Ivers 
et al., 2012). 
 The main strength of this systematic review was the large sample size of 140 randomized 
controlled trials that were analyzed and the RD being 4.3% (Ivers et al., 2012).  Another strength 
of this systematic review was the utilization of two independent authors, who initially reviewed 
the literature and further screened the articles according to the inclusion criteria (Ivers et al., 
2012).  Two weaknesses identified from this review were eliminating studies which did not 
contain baseline calculations and limiting the examination for certain factors based on practical 
use of abstracts (Ivers et al., 2012). 
 Ospina et al., 2017 organized a systematic review regarding the validity of utilizing 
COPD discharge care bundles when patients with COPD are discharged from the hospital.  An 
information specialist conducted an electronic database search, which was based on specific 
search criteria including COPD and discharge care bundles, in which documenting spirometry is 
a component (Ospina et al., 2017).  Two independent examiners reviewed the results and 
identified 5,863 studies.  A total of 14 different studies in 21 publications were included in the 
systematic review after removing duplicate studies, excluding records, excluding articles for 
other indications such as the bundle not being conducted at discharge, and removing multiple 
publications (Ospina et al., 2017).  Of the 14 studies, five were clinical trials, seven were 
SPIROMETRY AND COPD DIAGNOSIS   
 
20
uncontrolled trials, and two were interrupted time series (Ospina et al., 2017).  A random effects 
meta-analyses was performed of the clinical trials for readmission, mortality, and quality of life 
(Ospina et al., 2017). 
Ospina et al., examined a total of 14 studies with 26 different elements of care.  Four 
main trials revealed that these bundles reduced readmissions to the hospital, one of which 
included documenting spirometry.  One of the strategies identified in implementing this bundle 
was the chart audit and feedback.  Four of the clinical trials with moderate to high bias revealed 
that COPD discharge bundles lowered hospital readmissions with a pooled risk ratio of 0.80 with 
a 95% confidence interval and ranging from 0.65 to 0.99 (Ospina et al., 2017).  Although 
insufficient data was not able to reveal whether COPD discharge care bundles had a significant 
impact on long-term mortality or quality of life, the bundles likely reduced COPD exacerbated 
readmissions (Ospina et al., 2017).  The systematic review aspect of this manuscript was a major 
strength as well as its utilization of a meta-analysis (Ospina et al., 2017).  One weakness is the 
resulting smaller sample size being 14 studies and possible bias due to a lack of similarity and 
blinding (Ospina et al., 2017). 
Clinical Practice Guidelines 
 Global Initiative for Chronic Obstructive Lung Disease. The Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) 2017 guideline is a worldwide “strategy document” 
with the purpose to assist health care providers in diagnosing, managing, and preventing COPD 
(GOLD, 2017).  The GOLD program was initiated in 1998 and was developed to provide the 
best scientific information.  The first GOLD guideline was available in 2001.  Revisions have 
been made over the years with 2017 being the most recent version.  The purpose of the 2017 
report was to provide a non-biased, well-researched review of the provided evidence for 
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assessing, diagnosing, and treating patients with COPD.  A PubMed search was utilized by the 
GOLD science committee.  Search fields included: COPD, all-fields, adult, at least 19 years old, 
abstracts included, analyses, clinical trial, and human.  The literature update for this edition was 
published between 2015 and 2016.  The revised guidelines were distributed to 10 experts 
externally from the GOLD members.  The guidelines were revised based on these experts’ 
recommendations. 
 The levels of evidence were designated to certain recommendations and ranged from A to 
D.  A were those randomized controlled trials with at least two trials with a large sample size.  B 
also consisted of randomized controlled trials, but with some limitations such as a smaller 
sample size or flaws.  C indicated nonrandomized controlled trials or observational studies.  D 
were opinions of a panel.  According to the GOLD guidelines, one significant recommendation 
was provided which is valuable to this project; spirometry is necessary to confirm the diagnosis 
of COPD.  Spirometry continues to be vital in the diagnosis, determining the prognosis and 
nonpharmacological treatment of COPD.  Spirometry is the most objective and reproducible way 
to determine airflow limitation.  It is noninvasive and readily available in many areas.  
Spirometry should be utilized to assist in the confirmation process for the diagnosis of COPD. 
 One strength of this guideline is its expert committee members, who are known leaders 
with expert research and clinical experience with COPD.  Two independent committee members 
analyzed each abstract and recommendations made by these reviewers were discussed by the 
committee biannually.  One weakness of this guideline is the lack of documentation of the 
number of abstracts reviewed for the 2017 revision. 
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Randomized Controlled Trials 
 McClellan et al., 2003 developed a randomized controlled trial, with the purpose of 
determining whether an intervention involving a chart audit and feedback of hemoglobin A1C 
would cause more frequent monitoring.  Patients who met the diabetes criteria for the study were 
assigned to a randomized trial of randomly selected physicians in a southern American state 
(McClellan, Millman, Presley, Couzins, & Flanders, 2003).  The patient sample was about 
23,000 people and the physicians were about 477 in 123 counties (McClellan et al., 2003).  After 
assigning patients to physicians, each county was placed in alphabetical order and randomly 
assigned a number, which was used to assign to either the intervention or control group 
(McClellan et al., 2003).  The intervention utilized a claims-based feedback (McClellan et al., 
2003).  The researcher found that rates for the quality indicators increased as well as the rate of 
A1C testing from 13.0% to 16.8% (McClellan et al, 2003).  Therefore, chart audit feedback with 
education regarding A1C levels resulted in improved treatment for diabetic Medicare patients 
(McClellan et al., 2003).  This quality research study reveals the successful nature of chart audit 
and feedback, which is significant to this project.  The strength of this study was the randomized 
aspect as well as the large sample size (23,000 patients, 477 physicians, 123 counties) 
(McClellan et al., 2003).  Limitations include a possible over or underestimation, since indicators 
were initially assigned to the patients and then the providers (McClellan et al., 2003).  Another 
limitation is that the study occurred only within rural counties in a single state. 
 Thomas et al., 2007 conducted a randomized controlled trial with the purpose to examine 
the impact an audit, feedback, and patient reminder system would have on diabetes care.  The 
randomized controlled trial incorporated a total of 78 subjects to which 39 residents received the 
instructions, chart audit, feedback, and letter (Thomas et al., 2007).  Another 39 were in the 
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control group (Thomas et al., 2007).  Patients that were treated by the intervention group had an 
improved adherence to the A1C recommendations compared to the control group (Thomas et al., 
2007).  Therefore, using a chart audit and feedback system with providers improved diabetes 
care processes, although it did not necessarily impact the intermediate clinical results (Thomas et 
al., 2007).  The RCT aspect of this study was a major strength.  The inability to have binding 
because of the intervention was a limitation to this study (Thomas et al., 2007). 
A total of 1,236 subjects who were diagnosed with COPD were included in one 
randomized controlled study (Guerriero et al., 2015).  The aim of this study was to evaluate the 
prevalence of COPD in Northern Italy utilizing the GOLD and ERS/ATS criteria (Guerriero et 
al., 2015).  This randomized controlled study sent 5,000 invitation letters and 1,236 subjects 
were included based on reply and ability to perform spirometry (Guerriero et al., 2015).  The 
study utilized spirometry and physician assessment (Guerriero et al., 2015).  A total of 26.7% of 
subjects experienced daily pulmonary symptoms and only 30.7% had previously received 
spirometry (Guerriero et al., 2015).  The COPD prevalence depended on the criteria utilized: 
11.7% with the GOLD criteria, 9.1% LLN, and 6.8% physician diagnosis (Guerriero et al., 
2015).  Of the subjects previously diagnosed, 48.8% never received spirometry (Guerriero et al., 
2015).  Based on the prevalence of patients with COPD, an underdiagnosis/misdiagnosis of 
COPD occurs if spirometry was underutilized (Guerriero et al., 2015).  This may affect quality of 
life and fiscal means, that may be preventable if spirometry were utilized (Guerriero et al., 2015).  
The random aspect of this study is one main strength as well as the population size (Guerriero et 
al., 2015).  Also, the study utilized different criterion, which was more thorough.  One limitation 
was that the prevalence studied was confined to one specific area, which could limit the 
generalizability. 
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Quasi-experimental Trials 
 Walters et al., 2011 was a cross-sectional quasi-experimental trial, which was conducted 
with the purpose of quantifying the number of patients with COPD who were misclassified in 
primary care, and to identify the causes correlated with the misdiagnoses (Walters et al., 2011).  
A cross-sectional study was completed in 31 different practices in Australia (Walters et al., 
2011).  A total of 341 patients were eligible for the study based on their COPD diagnosis or 
prescription for Tiotropium (Walters et al., 2011).  The subjects were given spirometry testing 
and the results concluded that of the 341 patients with a COPD diagnosis/Tiotropium usage, 107 
were misclassified (Walters et al., 2011).  Misclassification was shown to be increased with 
overweight/obese patients and those that have reported allergic rhinitis (Walters et al., 2011).  
Basing a COPD diagnosis on symptoms in primary care may be inaccurate, especially with 
overweight patients (Walters et al., 2011).  The study highlighted the importance of utilizing 
spirometry to prevent improper management (Walters et al., 2011).  One strength of this study 
was that the intervention occurred across many different practices (Walters et al., 2011).  A main 
limitation was that the study examined patients with COPD in primary care only, and not an 
ambulatory setting (Walters et al., 2011). 
 One study examined if gender bias affected the diagnosis of COPD (Chapman, Tashkin, 
& Pye, 2001).  A random sample of 192 primary care physicians completed a hypothetical case 
study and follow-up interview (Chapman et al., 2001).  A hypothetical case study and interview 
was provided to the PCP’s and the outcome revealed that COPD was a more likely diagnosis to 
be given to a male by 16% (Chapman et al., 2001).  Primary care physicians underdiagnose 
COPD, especially with their female patients (Chapman et al., 2001).  Spirometry is underused 
and may ultimately reduce COPD under diagnosis along with gender bias (Chapman et al., 
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2001).  The random sampling method of selecting physicians was a strength (Chapman et al., 
2001).  A limitation included the lack of studying real encounters with patients, and the 
physicians background/training was not examined (Chapman et al., 2001). 
Other Evidence 
 13 other articles were analyzed for quality of data to provide further evidence for the 
need to use spirometry to confirm the diagnosis of COPD.  Each article had its own strengths and 
purpose and most limitations were related to having a lower level of evidence. 
Synthesis 
 Misdiagnosed COPD. Utilizing spirometry to confirm the diagnosis of chronic 
obstructive pulmonary disease (COPD) in the primary care setting is vital.  When a spirometry is 
not utilized in diagnosing COPD, inaccurate diagnoses are common.  One study utilized a cross-
sectional investigation to examine 341 patients in Australia who had a COPD diagnosis or were 
prescribed tiotropium with a general practitioner recognition (Walters et al., 2011).  Of the 341 
patients who were given spirometry, it was found that 31% (107) had been misclassified with 
COPD (Walters et al., 2011).  This study recognized the importance of using spirometry to 
diagnose COPD and also highlighted the unreliable nature of diagnosing a patient with COPD 
based on reported symptoms alone (Walters et al., 2011). 
 Spirometry also assists in avoiding a delay in treatment by not misdiagnosing COPD.  
Jagana, 2015, examined the cause of the delays in treating COPD (Jagana, Bartter, & Joshi, 
2015).  The study concluded that underutilizing spirometry in primary care was linked to COPD 
misdiagnosis (Jagana et al., 2015).  One interesting point discussed was that although the use of 
spirometry was available to 52% of subjects, only 31% actually utilized spirometry to confirm all 
of their COPD diagnoses and provide timely and appropriate treatment (Jagana et al., 2015).  
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Therefore, it is important to educate providers on the importance of utilizing the gold standard of 
spirometry to diagnose and not misdiagnose COPD (Jagana et al., 2015).  This study is of 
significant interest to this project because the main intervention of the project will be to educate 
primary care providers in the office setting to increase the usage of spirometry as the gold 
standard in diagnosing COPD.  This mirrors the Jagana study, which was to reduce the delay in 
diagnosing and treating COPD in primary care (Jagana et al., 2015). 
 COPD is not only unreliably diagnosed based on symptoms, but it is also often 
underdiagnosed based on patient identifying factors, such as gender.  One particular study 
examined 192 primary care physicians, to identify whether there was a correlation between 
diagnosing COPD and gender bias (Chapman, Tashkin, & Pye, 2001).  The study used a sample 
of primary care physicians and concluded that these providers were more likely to diagnose a 
male patient with COPD than a female (Chapman, Tashkin, & Pye, 2001).  The article also 
concluded that initially, only 22% of these physicians were likely to utilize spirometry to 
diagnose COPD (Chapman, Tashkin, & Pye, 2001).  Again the need for spirometry was 
confirmed in order to assist in a reliable diagnosis of COPD, but also to assist in avoiding 
identifying factors such as gender bias when diagnosing COPD. 
 Gender bias is not the only identifying factor that is associated with the lack of 
spirometry.  One study examined the correlation of patient and physician factors when ordering 
spirometry to confirm the diagnosis of COPD (Gershon, Hwee, Croxford, Aaron, & To, 2014).  
The population study examined 491,754 patients in Ontario, Canada (Gershon, et al., 2014).  It 
was concluded that only 35.9% of these patients who were newly diagnosed with COPD ever 
received a spirometry test (Gershon, 2014).  Therefore, spirometry is still underutilized in many 
areas, including Canada.  The article also highlighted a correlation between patient age, 
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comorbidity, and physician factors with the use of spirometry (Gershon, 2014).  Regardless of 
the factors associated with the lack of spirometry usage, it is clear that primary care providers 
need to increase their usage of spirometry to diagnose COPD. 
 The need for spirometry avoids empirically diagnosing or treating patients with COPD 
while concurrently misdiagnosing these patients.  One study examined patient safety concerns 
when providers empirically diagnose and treat patients regardless of spirometry results (Fortis, 
Corazalla, Jacobs, & Kim, 2016).  The article concluded that although only 7% of patients were 
empirically diagnosed with COPD, 82% of these patients were also empirically treated (Fortis et 
al., 2016).  The study highlighted the importance of primary care providers avoiding this 
improper treatment as it increases unnecessary costs of treatment as well as possibly resulting in 
avoidable adverse reactions (Fortis et al., 2016).  Therefore, although this project is attempting to 
increase spirometry, it is still important to consider that some providers may continue to 
empirically treat patients regardless of their spirometry results. 
 Avoiding misdiagnosing patients with COPD by utilizing spirometry, especially on those 
patients who are frequent exacerbators, is necessary.  One study was unique in that it explored 
the misclassifications among COPD and asthma patients that are prone to having frequent 
exacerbations (Jain et al., 2015).  333 patients were selected, who have had frequent 
exacerbations of either asthma or COPD and a retrospective chart review ensued (Jain et al., 
2015).  The article concluded that objectively confirming airway obstruction, especially among 
those with frequent exacerbations, was necessary compared to clinically diagnosing patients 
based on symptoms (Jain et al., 2015).  Spirometry was shown to greatly reduce the risk of 
misdiagnosing COPD or asthma (Jain et al., 2015).  This article further highlights the vital 
importance of confirming a COPD diagnosis with objective testing, such as with spirometry.  
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Another study was conducted in Latin America that examined the degree to which COPD was 
under or misdiagnosed in the primary care setting (Casas Herrera et al., 2016).  The article 
confirmed the need for spirometry to be increasingly utilized in primary care to avoid 
underdiagnosing and misdiagnosing COPD (Casas Herrera et al., 2016). 
 Spirometry is also necessary because a high percentage of patients are over diagnosed 
with COPD based on lack of use of spirometry.  One study examined the frequency of COPD 
overdiagnosis among underserved patients with a government qualified organization (Ghattas, 
Dai, Gemmel, & Awad, 2013).  A descriptive retrospective cohort study included 80 patients 
who were either previously diagnosed with COPD or receiving anticholinergic inhalers without a 
COPD diagnosis (Ghattas et al., 2013).  These patients were given spirometry testing and 
concluded that about 42.5% of these patients had no obstruction and 22.5% had a reversible form 
of obstruction (Ghattas et al., 2013).  Therefore, a high percentage of these underserved patients 
who were either treated for COPD or diagnosed as COPD did not objectively have COPD based 
on spirometry (Ghattas et al., 2013).  This study is helpful for this project, as it provides further 
evidence of the importance of ordering spirometry to confirm the diagnosis of COPD. 
 Spirometry also needs to be performed before patients are misdiagnosed with COPD, 
and/or admitted/readmitted.  Spero, 2017, examined the frequency of COPD overdiagnosis, but 
specifically analyzed patients in the hospital setting (Spero, Bayasi, Beaudry, Barber, & Khorfan, 
2017).  The purpose of the study was to examine the percentage of hospital COPD patients that 
received confirmatory testing with spirometry and to examine the accuracy of the diagnosis 
(Spero et al., 2017).  The study examined 6,018 patients with COPD in the hospital, of which 
504 had completed spirometry during their hospital stay (Spero et al., 2017).  Of the 504 
subjects, COPD was confirmed in 69.2%, 26.6% had a restrictive lung disease, and 4.2% had 
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normal spirometry (Spero et al., 2017).  One strength of this study was that it was conducted at a 
teaching hospital, which reflecting real-life scenarios with COPD (Spero et al., 2017).  This 
study highlights the necessity to diagnose COPD patients with spirometry in the primary care 
office setting before they become admitted and treated inaccurately due to a lack of objective 
COPD confirmation (Spero et al., 2017). 
 Appropriate use of Spirometry. Utilizing spirometry appropriately avoids the 
discharged patients from becoming “readmitted” incorrectly with COPD, which is of interest as 
it impacts cost savings and the considerable burden COPD has on the global healthcare system.  
Without spirometric confirmation of COPD, hospitalizations, readmissions, and utilization of 
COPD resources will be wasted.  One study examined patient safety concerns when providers 
applied the discharge diagnosis of COPD when spirometry was not utilized to confirm the 
diagnosis (Wu, Wise, & Medinger, 2017).  The study examined 826 patients in the Veterans 
Affairs (VA) health system after discharge with a COPD diagnosis (Wu, et al., 2017).  About 
21% of these patients had no spirometry measurements documented (Wu et al., 2017).  The study 
emphasized the need for providers to take caution when patients are discharged with a diagnosis 
of COPD, mainly if they had not received spirometry (Wu et al., 2017).  Without spirometric 
confirmation of COPD, COPD hospitalizations, COPD readmissions, and utilization of COPD 
resources will be wasted (Wu et al., 2017).  For example, if a COPD diagnosis is not confirmed 
with spirometry, they may become inaccurately readmitted with COPD negatively impacting 
cost savings for the hospital and placing a burden on the global health care system. 
 Appropriately utilizing spirometry avoids the underdiagnosis of COPD and helps identify 
those patients with COPD to allow for proper treatment and improve the quality of care 
provided.  One study examined the need for primary care providers to increase their usage of 
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spirometry to diagnose COPD (Mapel, Dalal, Johnson, Becker, & Hunter, 2015).  A multicenter, 
cross-sectional, observational study examined patients with COPD and estimated the physicians’ 
impressions and severity of the patient’s COPD (Mapel et al., 2015).  After completion of 
spirometry, the results concluded that without ordering spirometry, the primary care physicians 
were underestimating the disease severity of their patients with COPD (Mapel et al., 2015).  This 
negatively impacted quality of care provided for these patients (Mapel et al., 2015).  The use of 
spirometry for these patients changed the physician’s impressions of the severity of the disease 
for about one-third of these patients, further demonstrating the beneficial use of spirometry in 
diagnosing and treating patients with COPD (Mapel et al., 2015). 
 Lacking spirometry usage negatively impacts cost and quality of life issues.  A 
randomized cross-sectional study examined 1,236 subjects who were diagnosed with COPD 
(Guerriero et al., 2015).  Only approximately 48.8% of patients had completed spirometry prior 
to the initiation of the study (Guerriero et al., 2015).  The lack of spirometry use was associated 
with COPD misdiagnosis and especially underdiagnosis of COPD, which both lead to quality of 
life concerns as well as fiscal irresponsibility (Guerriero et al., 2015).  Since COPD is a 
progressive disease, to slow the progression one must diagnose promptly, and properly treat this 
disease (Guerriero et al., 2015).  Hence, mis/underdiagnosing COPD may lead to a lack of work 
and social quality of life (Guerriero et al., 2015).  The direct and indirect costs of treating COPD 
in stage one or two compared to severe COPD is a difference of about twice the cost (Guerriero 
et al., 2015).  Therefore, by diagnosing COPD early with spirometry, a cost savings can be 
recognized (Guerriero et al., 2015). 
 Improved outcomes with appropriate spirometry usage. Appropriately utilizing 
spirometry improves quality of life, patient safety, and cost savings.  One study examined 68,898 
SPIROMETRY AND COPD DIAGNOSIS   
 
31
patients who were diagnosed with COPD and discovered an interesting correlation (Gershon, et 
al., 2017).  Confirming the diagnoses of COPD utilizing spirometry is correlated with a 
decreased risk of mortality as well as admissions to the hospital for COPD (Gershon et al., 
2017).  This study utilized a longitudinal population analysis between 2005 and 2012 (Gershon 
et al., 2017).  Although some bias and confounding factors may have been identified, this study 
highlights the importance of improving quality of care and patient safety by confirming a 
diagnosis of COPD with spirometry (Gershon et al., 2017). 
Adhering to GOLD standards increases quality of life and provides cost savings.  One 
particular study investigated the clinical as well as cost saving benefits that resulted from 
adhering to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 
recommendations (Asche et al., 2012).  A retrospective cohort study design examined 364 
subjects and concluded that adhering to the GOLD recommendations not only had clinical 
benefits, but also provided cost savings (Asche et al., 2012).  This study is relevant to this project 
because it confirms evidence that staging COPD with spirometry as well as adhering to the 
GOLD recommendations not only increases quality of care, but also provides benefits with cost 
savings (Asche et al., 2012). 
 Improved outcomes with appropriate spirometry usage allows for proper treatment of 
those patients with COPD.  Walker, 2006 validated the need for spirometry to confirm a COPD 
diagnosis specifically in the primary care setting (Walker, Mitchell, Diamantea, Warburton, & 
Davies, 2006).  The study utilized a retrospective method to analyze if the use of spirometry in 
primary care ultimately increased the number of patients diagnosed with COPD (Walker et al., 
2006).  The study examined 1,508 subjects that were referred for spirometry, for which 235 
patients had post-bronchodilator obstruction (Walker et al., 2006).  Of the 235 patients, 130 of 
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them received a new diagnosis, mainly COPD (Walker et al., 2006).  The study concluded that a 
large portion of patients were undertreated before being referred for spirometry (Walker et al., 
2006).  Also, the use of spirometry increased the number of COPD patients who received proper 
treatment (Walker et al., 2006). 
Chart audit and provider feedback. Evidence from one strong systematic review (Ivers 
et al., 2012), one moderate systematic review (Ospina et al., 2017), one strong randomized 
controlled trial (McClellan et al., 2003), and one moderate randomized controlled trial (Thomas 
et al., 2007) supports the use of chart audit and feedback focused on improving provider 
adherence with confirming a COPD diagnosis with spirometry. 
  Ivers et al., 2012 identified chart audit and feedback as a successful method of improving 
healthcare provider compliance with evidenced-based practice.  Ospina et al., 2017 intended to 
review the success of COPD discharge care bundles, in which documenting spirometry is a 
component.  One strategy utilized was the chart audit and feedback method, which ultimately 
resulted in reduced readmission rates (Ospina et al., 2017).  Just as the chart audit and feedback 
system aided in improved results, an audit and feedback system was utilized in this project to 
improve provider compliance with ordering spirometry.  McClellan et al., 2003 identified a chart 
feedback and education, regarding A1C levels, resulted in improved treatment for diabetic 
Medicare patients.  This chart audit and feedback method can similarly be utilized to educate 
primary care providers on the need for spirometry to confirm a COPD diagnosis.  Thomas et al., 
2007 examined the impact a chart audit, feedback system, and patient reminder had on diabetes 
care.  The audit and feedback ultimately improved diabetes care processes (Thomas et al., 2007).  
Hence, a chart audit and feedback system has been proven through various studies to be an 
effective intervention to improve provider compliance. 
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Conceptual Framework 
The conceptual framework utilized for this scholarly project is the Iowa model.  The 
Iowa model was designed to assist clinicians in the evidenced-based practice (EBP) process to 
pursue a methodical approach in conducting and establishing an intended project (Iowa Model 
Collaborative, 2017).  The six main components of the Iowa model are: identifying a trigger, 
determining organizational priority, formulating a team, examining the evidence, implementing 
the change into practice, and analyzing the outcomes (Iowa Model Collaborative, 2017).  
Permission was provided by the University of Iowa, Department of Nursing to utilize the Iowa 
Model to initiate quality improvement for this scholarly project (Appendix C). 
Identifying the trigger. Identifying the trigger is the first step in promoting evidenced-
based practice (Iowa Model Collaborative, 2017).  Triggers may be problem or knowledge 
focused (Iowa Model Collaborative, 2017).  In this project, the problem focused trigger focuses 
on the idea that despite the 2017 GOLD guidelines and a plethora of other quality literature, 
approximately 30% of patients are misdiagnosed with COPD due to a lack of utilization of 
spirometry in the primary care setting. 
Organizational priority. The next step in the Iowa model is to decide if the topic is a 
priority (Iowa Model Collaborative, 2017).  As discussed in the literature review, a lack of 
spirometry usage to confirm COPD diagnosis has many negative ramifications.  These include 
insufficient quality of care, patient safety concerns, fiscal irresponsibility of the provider, and it 
causes a poor reflection on the organization. 
It is vital for this scholarly project to align with the mission and values of the 
organizational site.  If a gap exists between the project purpose/design and the organization, then 
the project must be re-formatted.  The organizational site determined for this scholarly project is 
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a primary care site in the state of Virginia.  Both the mission and vision of the site align closely 
with the intended scholarly project.  Focusing on quality care, while encouraging evidenced-
based practice through excellence, is foundational to the implementation of this scholarly project. 
Formulating a team. The next step in the Iowa model is to formulate a team and 
seamlessly collaborate through teamwork (Iowa Model Collaborative, 2017).  Teamwork is 
necessary to implement an evidenced-based practice change to proficiently provide the quality 
improvement needs.  The team members include the team leader who organized the project, 
implemented the educational feedback method, and completed the chart audits.  The committee 
chair provided mentorship, guidance, and feedback with the on-going process.  Also, a 
measurement consultant formulated and analyzed statistical results. 
Examine the evidence. The next step in the Iowa model is to examine the evidence 
(Iowa Model Collaborative, 2017).  An extensive literature review process occurred and was 
reviewed by the project chair.  The evidence has also been discussed with administration of the 
organizational site and will continue to be shared with the various team members as well as the 
providers who are to receive the educational intervention. 
Implement the change into practice. The next step in the Iowa Model is to develop and 
pilot the practice change of educating primary care providers on the importance of ordering 
spirometry to confirm a COPD diagnosis (Iowa Model Collaborative, 2017).  Ivers et al., 2012 
identified chart audit and feedback as a successful method of improving healthcare provider 
compliance with evidenced-based practice.  Providing regular feedback to providers regarding 
their adherence to the GOLD guidelines is essential in providing quality care. 
The pre-intervention process was established through completing a chart audit that 
identified patients with a primary or secondary diagnosis of COPD who visited the primary care 
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office within the last 30 days.  This was the baseline chart audit and required a measurement of 
the patients diagnosed with COPD who had spirometry as well as the number of patients 
diagnosed with COPD who never had spirometry completed.  The intervention portion was 
planned and conducted, which was an educational presentation delivered to the providers in the 
primary care office setting on the importance and benefits of ordering spirometry to confirm the 
diagnosis of COPD.  The presentation highlighted the average percentage of patients that are 
often misdiagnosed without using spirometry and the GOLD standard of ordering spirometry to 
confirm the diagnosis of COPD.  A survey was given to the providers before and after the 
presentation.  Another designing and implementation step was to provide a handout in the office 
setting to encourage the providers to continue to order spirometry prior to diagnosing COPD. 
 Analyze outcomes. The last main step was to implement the evaluation plan, which 
involved a post-intervention chart audit.  A 30-day and 30 to 60-day post intervention chart audit 
was conducted.  The rationale is that much improvement may not be seen at the 30-day, but may 
at the 60-day audit.  If only one audit occurred, and there was no improvement at the 30-day, but 
there was improvement at the 60-day, an average of both the 30 and 60-day post intervention 
may be negatively skewed.  The chart audit examined the number of patients diagnosed with 
COPD who had spirometry or were referred for spirometry as well as the number of patients 
diagnosed with COPD who did not have a spirometry referral. 
Once the implementation process was completed, a determination of whether the change 
would be appropriate for adoption in the primary care setting needed to occur (Iowa Model 
Collaborative, 2017).  A sustainable method for the project would be to focus on engaging 
specific staff personnel, such as administration, nurses, and providers, to continue to follow the 
GOLD recommendations with ordering spirometry.  This could be done by keeping visual 
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reminders in the office setting, such as small posters or notices (GOLD, 2017).  Also, another 
chart audit in the future could continue to measure the impact the presentation and reminders had 
on increasing spirometry in the primary care office site as time elapses. 
The final step in the Iowa model is to disseminate the results (Iowa Model Collaborative, 
2017).  Dissemination will occur by discussing the results of this project with key stakeholders 
including the Medical Director and other providers with the primary care site.  Conducting 
another presentation to discuss the results of the post chart audit would be beneficial for the 
providers in the office site to illustrate the benefits of the project and identify further inquiry 
needs.  Publishing the results in a journal as well as creating a poster for appropriate conferences 
to improve the number of COPD patients who are diagnosed with spirometry confirmation is 
another planned component of the dissemination plan. 
Summary  
 The purpose of this literature review was to identify the clinical problem, identify a 
successful intervention, provide beneficial goals and objectives, and provide outcome 
measurements.  The critical appraisal of data provides strong evidence with apparent quality.  
The strong systematic review (Ivers et al., 2012) provides evidence of the success a chart review 
and feedback has on provider compliance with evidenced-based practice.  The GOLD guidelines 
recommend utilizing spirometry to confirm the diagnosis of COPD.  Utilizing spirometry to 
confirm the diagnosis of COPD assists in preventing misdiagnoses, avoids “readmissions” with 
COPD, improves outcomes and patient safety concerns, improves quality of life, is fiscally 
beneficial, and reduces the global burden COPD has on our health care system.  This literature 
review supports the need for this project, which is to increase the number of COPD patients 
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diagnosed with spirometry by utilizing a chart audit and feedback system with primary care 
providers. 
Methodology 
Design 
 The purpose of this scholarly project was to implement a chart audit and feedback 
method aimed at educating primary care providers to increase the ordering of spirometry to 
confirm the diagnosis of COPD.  The goal of this project was to promote an EBP change in 
primary care to improve the quality of care provided.  The project design was conducted based 
on evidence and structure of the Iowa model.  The trigger and organizational priority have been 
identified and a team has been formulated.  The team members include the team leader, the 
committee chair, assistance from the measurement consultant, and support from various 
administration. 
 The team leader audited charts for a total of 150 patients with COPD as one of their 
diagnoses.  These patients must have had visited the primary care office in the last 30 days and 
charts were scanned for spirometry.  This was completed prior to the educational intervention.  
An aggregate group performance data was measured and provided to the participants during the 
educational piece.  During the educational feedback method, the providers were educated on the 
2017 GOLD guidelines, focusing on the recommendations of the importance of appropriately 
ordering spirometry to confirm the diagnosis of COPD.  Before and after the educational 
intervention, a survey was provided to examine if the behavior intention of the providers had 
changed.  Two handouts were given after the educational intervention to the providers in the 
office.  A 30-day and 30 to 60-day post intervention chart audit was subsequently completed to 
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examine whether an increased number of patients diagnosed with COPD received an order for 
spirometry. 
Measurable Outcomes 
1. After completion of the educational feedback, providers in a primary care setting will 
demonstrate a behavior intention change of the guidelines for ordering spirometry to 
confirm the diagnosis of COPD.  This will be evidenced by an increased average in 
the Likert score for all four questions. 
2. After completion of the chart audit and feedback method, providers in a primary care 
setting will improve their usage of EBP guidelines as evidenced by an increase 
number of documented spirometry to confirm the diagnosis of COPD. 
Setting, Population, Sample 
 A primary care office setting in Virginia was chosen as the site for the prospective 
scholarly project.  The office providers include physicians, nurse practitioners (NP’s), and 
physician assistants (PA’s).  The Medical Director of the organization has provided a letter of 
support for the site (Appendix F).  The sample comprises of two different populations: (1) 
primary care providers (physicians, nurse practitioners, and physician assistants), (2) adult 
patients with COPD as one of their diagnoses. 
 The inclusion criteria for the first population includes physicians, NP’s, and PA’s 
practicing in the primary care setting.  The exclusion criteria for the first population includes 
non-providers and those who choose not to participate.  A total of 6 providers were included in 
the project.  The inclusion criteria for the second population includes patients with COPD as one 
of their diagnoses, age ≥ 18 years old, and <90 years old.  The exclusion criteria for the second 
population includes patients who do not have COPD as one of their diagnoses, <18 years old, ≥ 
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90 years old, or under the care of palliative or hospice service.  All of the primary care providers 
and patients with COPD who meet the inclusion criteria, without exclusion criteria, were 
candidates for the scholarly project.  However, a cap of 50 patient charts was incorporated for 
each audit. 
Ethical Considerations 
 All members of the project team have completed research ethics training to ensure the 
protection of human rights.  A copy of the Collaborative Institutional Training Initiative (CITI) 
certificate is provided in Appendix B.  A submission of the final project to the Institutional 
Review Board (IRB) of the University was approved by the chair.  The project was also 
submitted to the organization’s IRB for approval as well.  Appendix H and I, respectively display 
the University’s and the organization’s approvals.  The project leader conducted the chart audit.  
A total of 50 charts for the pre and 50 for the post intervention audits were examined.  A master 
code book was created, which contained each charts’ medical record number, date of service, 
and the chart identification assigned code.  The master code book was created in an Excel 
spreadsheet and saved as a password-protected document and saved on a password-protected, 
health information and portability accountability act (HIPAA) compliant computer.  De-
identified data was kept separate on a password protected computer.  Data documented with the 
chart audit tool, survey, and data analysis documents was de-identified of any patient and 
provider information.  The data collector maintained the master code book set as a password 
protected document on a password protected HIPAA compliant computer for 3 years after 
completion of the scholarly project.  No copies will be made of the master code book and it will 
be eliminated from the computer after 3 years.  No patient or primary care provider identifying 
information associated with any presentation or publication of this project will be done. 
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Intervention, Tool, Data Collection 
 A baseline pre-chart audit was conducted through the electronic medical record system at 
the organization to identify patients who have COPD as one of their diagnoses and visited the 
office within the prior 30 days.  Also, any existing spirometry documentation was examined.  A 
non-random sampling, purposive, method was utilized for this project.  The sample size included 
up to 50 charts per audit that contained the inclusion without the exclusion criteria.  The data was 
entered into Microsoft excel and analyzed with the help of a measurement consultant. 
An educational feedback method was conducted by the team leader, which reviewed the 
objectives, background, benefits, 2017 GOLD guidelines, the problem, aggregate group 
performance data, with a main focus on the necessity to confirm the diagnosis with spirometry, 
and implications for practice.  A survey was provided before and after the educational 
intervention to examine if the behavior intention of the providers changed.  The survey was 
adapted and modified with permission as shown in Appendix D from the article titled Barriers to 
Adherence to COPD Guidelines Among Primary Care Providers (Perez, Wisnivesky, 
Lurslurchachai, Kleinman, & Kronish, 2012).  The survey was utilized in the project to examine 
the behavior intention of the providers based on COPD and the GOLD guidelines (Perez et al., 
2012).  Completed in writing, the survey only took about 2-4 minutes.  The survey was answered 
with a Likert scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 strongly agree 
(Appendix G).  The scored ranged from 1-5 with the low score of 1 reflecting the provider’s lack 
of intention for change and a high score of 5 reflecting an intention for change.  A calculated 
average for the pre and post-intervention examined if a behavior intention change has occurred.  
The data was entered into Microsoft excel and analyzed.  After the educational intervention, a 
handout was implemented to the primary care providers to remind providers of some of the 
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GOLD guidelines, particularly spirometry testing.  A 30-day and 30 to 60-day post intervention 
chart audit occurred to examine if an increase number of patients diagnosed with COPD received 
spirometry ordering. 
Timeline of project stages. 
Preparation. 
 Aligning with the Iowa Model, the team leader already identified the problem focused 
trigger, determined it was a topic priority for the organization, created a team, formulated 
research and reviewed the available literature, and decided there was a sufficient research base.  
The following steps were executed based on the proposed timeline: 
• By February 9th: Complete primary defense with chair 
• By February 16th: Submit proposal to University’s IRB 
• By February 27th: Submit proposal and Universities IRB acceptance letter to site’s IRB 
Implementation. 
 Aligning with the Iowa Model, the evidenced-based practice project was implemented 
into practice.  The following steps were executed based on the proposed timeline: 
• By March 30th: Conduct pre-intervention chart audit (Retrospectively from February 28th-
March 28th) 
• March 30th: Conduct educational feedback method with primary care providers in the office, 
and survey was provided before and after education. 
• May 2nd: Conduct 30-day post-intervention chart audit (Retrospectively from April 1st-May 
1st) 
• June 2nd: Conduct 60-day post-intervention chart audit (Retrospectively from May 1st-June 
1st) 
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Evaluation. 
Aligning with the Iowa Model, the evidenced-based practice project was evaluated.  The 
following steps are in the process of being executed based on the proposed timeline: 
• By June 16th: Post-intervention chart audits analyzed 
• By July 16th: The written scholarly project finished editing and sent to the editor 
• By July 23rd: Editor will return paper with recommendations 
• By August 3rd: Final defense will be conducted with chair 
• By August 10th: Final revisions will be made and project posted to the Digital Commons 
• By August 10th: Disseminate to key stakeholders 
Feasibility Analysis 
 A feasibility analysis was performed and includes examination of personnel, 
resources/technology, and a cost-benefit analysis was completed. 
 Personnel. 
• Team leader 
• Scholarly project chair  
• Administration/Primary care providers 
• Statistical Consultant 
 Resources/Technology. 
• Electronic medical record (EMR) system 
• Provider feedback survey 
• Computer 
• Excel 
 Other. 
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• Lunch budget 
Cost-Benefit Analysis 
 The cost of this project reflects mainly the budget for lunch and the editor.  The benefits 
of this project include possible reduced COPD readmissions, improved patient outcomes and 
safety concerns, improved quality of life, fiscal benefits, and that it may ultimately help in 
reducing the global burden COPD has on the health care system.  The cost of this project is 
seemingly low, but the benefits as discussed are relatively high.  Therefore, the benefits 
outweigh the cost of this project. 
Evaluation/Data Analysis 
 Objectives: 
1. After completion of the educational feedback, providers in a primary care setting will 
demonstrate a behavior change with the guidelines for ordering spirometry to confirm 
the diagnosis of COPD.  This will be evidenced by an increased average in the Likert 
score for all four questions. 
2. After completion of the chart audit and feedback method, providers in a primary care 
setting will improve their usage of EBP guidelines as evidenced by an increase 
number of documented spirometry to confirm the diagnosis of COPD. 
 Objective 1: Impact behavior intention for primary care providers. 
 Method and design. 
 A quasi-experimental, one group pre-test/posttest design was completed to examine the 
impact an educational interventional feedback method has had on the behavior intention of 
primary care providers with guidelines for ordering spirometry to confirm the diagnosis of 
COPD. 
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 Sample. 
 The sample comprised of primary care providers (physicians, NP’s, PA’s).  A 
nonrandom, purposive, convenient sampling is suggested for the primary sample method.  A 
total of 6 providers were employed at the primary care office.  A total of 18 providers in the 
office were sent a recruitment email (Appendix E).  The inclusion criteria for the first population 
includes physicians, NPs, and PAs practicing in the primary care setting.  The exclusion criteria 
for the first population includes non-providers and those who choose not to participate. 
 Data Collection/Tool. 
 The survey is adapted and modified with permission as shown in Appendix D from the 
article titled Barriers to Adherence to COPD Guidelines Among Primary Care Providers (Perez 
et al., 2012).  The survey only took about 2-4 minutes and was completed in writing.  The survey 
was answered with a Likert scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 
strongly agree.  The average was calculated for the pre and post-intervention to examine if the 
behavior intention of the providers has changed.  During the educational feedback method, the 
providers were educated on the 2017 GOLD guidelines, focusing on the recommendations of the 
importance of appropriately ordering spirometry to confirm the diagnosis of COPD. 
 Statistical Analysis. 
 The dependent variable of interest (provider behavior intention) is presented with a Likert 
scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 strongly agree (Appendix G).  The 
average was calculated for the pre and post-intervention examining if a behavior intention 
change has occurred.  The data was entered into Microsoft excel and analyzed. Descriptive 
statistics and analysis (mean) was conducted to examine provider behavior intention with the 
GOLD guidelines for spirometry ordering (Appendix G). 
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 Objective 2: Primary care providers will increase the number of documented 
spirometry to confirm the diagnosis of COPD. 
 Method and design. 
 A quasi-experimental, one group pre-test/posttest design was utilized to examine the 
impact a chart audit and educational feedback method has had on the primary care providers’ 
usage of EBP guidelines as evidenced by an increase number of documented spirometry to 
confirm the diagnosis of COPD. 
 Sample. 
 The sample populations were adult patients with COPD as one of their diagnoses (J 44).  
The inclusion criteria included patients with COPD as one of their diagnoses, age ≥ 18 years old, 
and < 90 years old.  The exclusion criteria included patients who did not have COPD as their 
diagnosis, <18 years old, ≥ 90 years old, or under the care of palliative or hospice service.  The 
number of patients who met the inclusion criteria for the chart audit was 50 charts per chart 
audit.  Therefore, a maximum of 50 charts for the pre chart audit, 50 charts for the 30-day post 
chart audit, and 50 charts for the 30 to 60-day post chart audit was analyzed. 
Data Collection/Tool. 
A 30-day retrospective chart review was implemented for pre-intervention information and a 
30-day and 60-day post intervention audit.  Data collection proceeded as follows: 
1. A chart search method for population identification was performed by the assistants and 
the project leader reviewed the identified patients for inclusion and exclusion criteria. 
a) Searched medical record for patients with COPD as a diagnosis (J 44) 
b) Narrow search by visited date range (previous 30-day period) 
c) Narrow search by patient age in years (18 years or older) 
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d) Narrow search to by patient in years (89 years or younger) 
2. The project leader evaluated the chart to examine if spirometry was documented. 
The post chart audit was conducted in the same way as the pre chart audit, with the 
modification of changing the search visited date range to the previous 30-day and 60-day. 
3. A master code book was created, which contained each chart’s medical record number, 
date of service, and the chart identification assigned code.  The master code book was 
created in an Excel spreadsheet and saved as a password-protected document and saved 
on a password-protected, health information and portability accountability act (HIPAA) 
compliant computer.  De-identified data was kept separately on a password protected 
computer.  Data documented with the chart audit tool, survey, and data analysis 
documents was de-identified of any patient and provider information. 
4. The data collector will maintain the master code book set as a password protected 
document on a password protected HIPAA compliant computer for 3 years after 
completion of the scholarly project.  No copies will be made of the master code book and 
it will be eliminated from the computer after 3 years.  No patient or primary care provider 
identifying information associated with any presentation or publication of this project 
will be done. 
 Statistical Analysis. 
Statistical analysis was conducted in two phases: pre and post intervention.  One 
statistical method, a statistical z-test, comparing the percentages of each sample was used to 
evaluate objective 2.  The percentages reflect the number of patients who have had spirometry 
documented from the whole sample of COPD patients.  This test was used for the pre and post 
intervention to compare the number of spirometry tests documented pre and post intervention. 
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Results 
 A total of 18 providers were invited to participate in this scholarly project with 6 
providers actually participating who met the inclusion criteria without the exclusion criteria.  A 
total of 150 charts were audited, with 50 charts for the pre, 50 for the 30-day, and 50 for the 60-
day post-intervention chart audits.  The various demographics of the primary care providers, 
sample size, assumptions, significant findings, and a summary of the results is provided. 
Demographics 
 Sample size. A total of 6 providers who participated in this scholarly project (n=6).  The 
pre and post survey were collected on all 6 providers.  The chart audits included a total of 150 
(n=150), with 50 being the pre chart, 50 for the 30-day, and 50 for the 60-day post-intervention 
audit. 
 Years of experience. Of the 6 providers who participated, 1 had less than 5 years of 
experience, 1 had 5-10 years of experience, 2 had 11-20 years of experience, 2 had greater than 
20 years of experience; see figure 1. 
 
Figure 1. Years of Provider's Experience. 
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 Type of healthcare profession. There was a total of 3 physicians, 2 nurse practitioners, 
and one physician assistant who participated in this scholarly project; see figure 2. 
 
Figure 2. Type of Provider Healthcare Profession. 
Assumptions 
 There were two main assumptions made during this scholarly project.  The first 
assumption was that the participants answered the questions honestly and not as they thought 
they should answer the questions.  The second assumption was that the providers ordered 
spirometry to confirm a COPD diagnosis, rather than for other reasons. 
Main Findings 
A total of 50 patients diagnosed with COPD who visited the primary care office within 
the prior thirty days were included in the pre-chart audit.  A total of 50 patients for the 30-day 
and 50 patients for the 60-day post-chart audits were included.  The pre-chart audit revealed that 
27/50 (54%) of patients had previously had spirometry documented to confirm a COPD 
diagnosis.  Thirty-day post chart audit and feedback intervention 33/50 (66%) and sixty-day post 
chart audit and feedback intervention revealed 31/50 (62%) of patients had spirometry 
documented to confirm a COPD diagnosis (see table 1 and figure 3). 
SPIROMETRY AND COPD DIAGNOSIS   
 
49
 
Table 1 
Documented Spirometry Rate 
Stage Documented Spirometry 
Pre-chart Audit 27 
30-day Post 33 
60-day post 31 
 
 
Figure 3. Documented Spirometry Rate. 
During the three chart audits, spirometry ordering trends were also analyzed based on the 
dates that the spirometry tests had been ordered (see table 2 and figure 4).  Those ordered less 
than 30 days prior revealed an increase from the pre to 30-day and a slight increase from pre to 
60-day post-chart audit.  The 30-day to 6 months was about the same with a 3, 3, and 2 result.  
The 6 months to 1-year period was a 2, 3, 2.  The 1 to 2-year period was a 5, 4, 1.  Finally, 
greater than 2 years was a 17, 18, 24 results.  This suggests no obvious spirometry referral trend.  
However, further research maybe able to examine for a lengthier and larger sample size trend. 
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Table 2 
Spirometry Referral Trend 
 
 
 
Figure 4. Spirometry Referral Trend. 
The survey was conducted before and after the providers were educated on the 
importance of ordering spirometry to confirm the diagnosis of COPD (Appendix A).  The survey 
took about 2-4 minutes and was completed by providers in writing.  The survey is answered with 
a Likert scale from 1-5 with 1 being strongly disagree, 3 neutral, and 5 strongly agree.  The 
average was calculated for the pre and post-intervention and examined whether a behavioral 
intention has occurred.  The score reflected behavioral intention; the higher the score, the more 
Stage <30d 
30d-
6m 
6m-
1y 
1y-
2y >2y 
Pre 0 3 2 5 17 
30-day post 5 3 3 4 18 
60-day post 2 2 2 1 24 
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likely the provider was to order spirometry to confirm a COPD diagnosis.  The pre-survey 
average totaled 3.17/5.  The post survey average totaled 4.33/5.  The pre to post-intervention 
survey of 6 providers revealed an increase behavior intention from 63.4% to 86.6%, which is a 
23.3% increase in behavior intention.  Therefore, there is a 23.3% increased likelihood that the 
providers will order spirometry to confirm their COPD diagnosis. 
 Two-proportions Z-test. A two-proportions Z-test was conducted with α = 0.05.  The Z-
test at 30 days revealed the P-value corresponding to z-1.225 is 0.112.  The Z-test from the pre-
chart audit to the 60-day post-chart audit revealed the P-value corresponding to z-0.8104 is 
0.2088. 
Summary of Results 
 The outcomes for this scholarly project were measured as follows: (1) increased primary 
care provider behavior intention to order spirometry to confirm a COPD diagnosis and (2) 
increased number of documented spirometry referrals. 
Outcome 1. Increased primary care provider behavior intention to order spirometry 
to confirm a COPD diagnosis. As identified by the post survey, the primary care providers 
were more likely to order spirometry to confirm the diagnosis of COPD following the 
intervention.  These results were identified as the average of the pre to post-intervention survey 
of 6 providers revealed an increase behavior intention from 63.4% to 86.6%, which is a 23.3% 
increase in behavior intention.  Therefore, there is a 23.3% increased likelihood that the 
providers will order spirometry to confirm their COPD diagnosis. 
Outcome 2. Increased number of documented spirometry referrals. As the two-
proportions Z-test revealed, which was conducted with α = 0.05, the Z-test at 30 days revealed 
the P-value corresponding to z-1.225 is 0.112.  The Z-test from the pre-chart audit to the 60-day 
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post-chart audit revealed the P-value corresponding to z-0.8104 is 0.2088.  Therefore, although 
there is not significant statistical evidence for either Z-test, there is a clinically significant 
increase in spirometry referrals documented. 
Discussion 
The purpose of this scholarly project was to determine the effectiveness of using a chart 
audit and feedback method to educate primary care providers on confirming COPD diagnosis 
with spirometry.  The results of this project show that although there is not significant statistical 
evidence for either Z-test, there is clinical significance.  Despite the fact that the results did not 
reveal statistical significance in increasing the number of patients who received spirometry, there 
are a number of positive outcomes.  The literature review documented a plethora of research, 
clinical guidelines, and documented benefits concerning the significance of ordering spirometry 
to confirm the diagnosis of COPD.  The limitations and clinical implications of this project need 
to be considered for any further exploration of the need for spirometry to confirm the diagnosis 
of COPD. 
Strengths 
 Strengths of this project include the following: (1) cost effectiveness, (2) multiple 
methods of data collection, and (3) the swift rate of collecting data.  The cost of this project was 
minimal and required no outside fiscal assistance.  The multiple methods of data collection 
included the surveys as well as the chart audits, thereby yielding a well-rounded project and 
reducing bias.  Finally, obtaining outcomes in a short time frame assisted in completing and 
obtaining results quickly. 
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Limitations 
 Limitations to this project include the following: (1) time, (2) chart sample (3) provider 
sample size (4) manual process of locating spirometry results in the charts, and (5) repeat 
patients from one audit to another.  Auditing charts for only 60 days after the educational 
intervention was not long enough to reveal a trend towards increasing spirometry referrals.  
Further studies could lengthen the timeline in order to examine for a trend towards ordering 
spirometry to confirm a COPD diagnosis.  In addition, a larger sample size of audited charts 
being only 50 patients is not quite ideal for this project.  A larger sample size of both charts and 
providers would have more accurately reflected the population of COPD patients and primary 
care providers as a whole. 
 The manual process of locating spirometry results in the charts was a definite limitation.  
Because of the amount of information that needed to be manually examined in each chart, it was 
possible to miss spirometry documentation.  If spirometry were to be succinctly documented in 
the medical record, the results would be more definitive.  Finally, some patients who visited the 
office during the pre-chart audit time frame may have also visited the office during the 30 or 60-
day post chart audit period.  Hence, some results may have been slightly impacted due to this 
occurrence.  Additional use of electronic medical record analysis may be one solution to this 
difficulty. 
Implications for Practice 
 Although there was no statistical significance of this project, one of the purposes was to 
increase the awareness of the primary care providers of the importance of ordering spirometry to 
confirm the diagnosis of COPD.  The results of this scholarly project indicate that there was 
clinical significance, as an increase in the number of spirometry ordering and a slight trend 
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towards more spirometry ordering can be assumed.  Therefore, a chart audit and educational 
feedback method is clinically beneficial in assisting providers in the primary care setting to 
incorporate spirometry to confirm the diagnosis of COPD.  The results also indicate that a chart 
audit and feedback method can be utilized in the primary care setting to enact and promote an 
evidenced-based practice. 
 Utilizing spirometry to confirm the diagnosis of COPD is a GOLD guideline and is 
considered vital (GOLD, 2017).  The multiple benefits can be appreciated including its 
assistance in avoiding misdiagnosing COPD, cost saving approaches, and reducing the 
considerable burden COPD has on the healthcare system (Walters et al., 2011 & Fortis et al., 
2016).  It also helps prevent inaccurate COPD readmissions and improve the patient’s quality of 
life/outcomes (Guerriero et al., 2015).  These benefits, a plethora of other literature, and the 
findings of this EBP project encourage the use of a chart audit and educational intervention 
method to promote the use of spirometry to confirm the diagnosis of COPD. 
As literature and this project reflect, many primary care providers, including this primary 
care site, have not been utilizing spirometry and its multitude of benefits to confirm the diagnosis 
of COPD.  This problem needs to continue to be addressed in clinical practice in the primary care 
setting to promote the benefits and prevent the issues of not utilizing spirometry in this manner.  
Since COPD continues to be one of the greater causes of readmissions in the United States 
according to the U.S. Centers for Medicare and Medicaid (CMS), the more promptly and 
accurately the diagnosis is made, the sooner patient safety and quality of care can be improved 
(CMS, n.d.). 
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Implications for Research 
 Further research is recommended to be completed on a greater scale, with a larger sample 
size, and longer period of time to more accurately examine whether a chart audit and feedback 
method is beneficial in impacting EBP projects such as this project.  More research should be 
conducted to observe the direct benefits of utilizing spirometry to confirm the diagnosis of 
COPD including the fiscal aspect, patient quality of care, and morbidity and mortality rates.  
Also, readmissions and a cost savings approach in this manner should be considered and 
examined. 
 More research can also be examined in regards to this particular project as further chart 
audits could be completed in 3 months, 6 months, and 1 year to determine if a trend is occurring.  
Finally, another survey could be completed to examine whether the primary care site’s providers 
could identify benefits or challenges in ordering spirometry according to the GOLD guidelines. 
Dissemination plan 
 The dissemination plan needs to be addressed as this is vital to spread the findings of this 
project to the target audience as well as educate providers on the importance of ordering 
spirometry to confirm a COPD diagnosis.  The goals of the dissemination plan are as follows: 
1. Educate primary care providers about the importance of ordering spirometry to confirm 
the diagnosis of COPD. 
2. Encourage the primary care providers at the site to continue to order spirometry to 
confirm their diagnoses of COPD. 
3. Educate the public about the benefits of utilizing a chart audit and feedback method to 
promote evidenced-based practice. 
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4. Educate the public regarding the benefits of ordering spirometry to confirm the diagnosis 
of COPD. 
 The dissemination plan will be conducted by the project leader.  The first step of the 
dissemination plan is to share the findings with the providers at the primary care site as well 
as the medical director.  A presentation will be provided over email, which will include bar 
graphs and tables to demonstrate the results.  Dissemination of the project will also be 
planned through a submission of a poster presentation to be presented at a conference in New 
York state.  This will ultimately have a target audience of clinical professionals including 
nurses, nurse practitioners, physician assistants, or physicians.  This project will also be 
submitted to the Digital Commons to reach a broader audience.  Finally, a manuscript 
submission to a journal will be completed. 
Conclusion 
 Despite being a GOLD guideline and having documented benefits, confirming a COPD 
diagnosis with spirometry is not routinely done in the primary care setting (Walters et al., 2011).  
The purpose of this project was to increase referrals for spirometry to confirm COPD diagnosis 
and to determine the effectiveness of using a chart audit and feedback method to educate primary 
care providers on confirming COPD diagnosis with spirometry.  A quasi-experimental design 
was incorporated in a primary care office.  A retrospective pre-intervention chart audit and two 
post-chart audits, at 30 and 60 days compared the frequency of documented spirometry to 
confirm a COPD diagnosis.  An educational intervention with a pre and post-survey examined 
whether the intervention changed provider behavior intention to order spirometry to confirm a 
COPD diagnosis.  Although there was not a statistically significant increase in the number of 
spirometry referrals, there was a clinically significant increase.  After implementing a chart audit 
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and educational intervention, the provider’s behavior intention also increased.  Hence, a chart 
audit and educational intervention is helpful to improve primary care provider’s behavior 
intention for specific clinical practice guidelines as well as a clinical increase in the evidenced-
based practice goal.  Further research is necessary to determine if other settings would have 
similar results. 
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Appendix A 
Literature Matrix Review. 
Author (year) Study Purpose/ 
Objective(s) 
Design, 
Sampling 
Method, & 
Subjects 
LO
E 
Intervention & 
Outcomes 
Results Study 
Strengths & 
Limitations 
Global Initiative 
for Chronic 
Obstructive Lung 
Disease (GOLD) 
(2017). 
The purpose of 
this report is to 
provide non-
biased, well-
researched 
review of the 
provided 
evidence for 
assessing, 
diagnosing, and 
treating patients 
with COPD.  
A PubMed 
search was 
utilized by the 
GOLD 
science 
committee.  
The search 
fields 
included: 
COPD, all-
fields, adult, 
at least 19 
years old, 
abstracts 
included, 
analyses, 
clinical trial, 
I Spirometry is 
necessary to 
diagnose COPD. 
Spirometry 
continues to be 
the key in 
diagnosis, 
determining 
prognosis, and 
nonpharmacolog
ical treatment. 
Strengths 
include the 
consistent 
treatment 
objectives and 
the simplicity of 
the COPD 
severity 
classifications.  
A study 
limitation was 
not identified in 
this evidenced-
based clinical 
guideline. 
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human.  The 
literature 
update for this 
edition was 
published 
between 2015 
and 2016. s 
Ivers, Jamtvedt, 
Flottorp, Young, 
Odgaard-Jensen, 
French, … Oxman 
(2012). 
The purpose of 
this systematic 
review was to 
examine the 
impact audit and 
feedback has on 
healthcare 
professionals’ 
practice and 
patient 
outcomes.  The 
aim is also to 
examine the 
cause of the 
differences 
between the 
A systematic 
review of 140 
randomized 
controlled 
trials were 
examined, 
which utilized 
audit and 
feedback with 
healthcare 
professionals. 
A multivariate 
meta-
regression 
was utilized to 
evaluate the 
I A weighted mean 
risk difference of 
0.5% to 16% 
increase in 
provider 
compliance 
resulted.  26 
comparisons with 
21 studies 
revealed a 
weighted median 
change to control 
was 1.3%. 
Although small, 
chart audit and 
feedback is 
effective in 
improving 
healthcare needs.  
The 
effectiveness is 
impacted by 
baseline 
performance and 
the system of 
feedback. 
The strength of 
this study was 
the nature of it 
being a 
systematic 
review of 140 
studies.  One 
main limitation 
was that some 
lack of 
documentation 
may have 
caused some 
reporting bias. 
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effectiveness of 
various chart 
audit and 
feedback. 
differences 
between the 
effectiveness 
of chart audit 
and feedback.  
Ospina, Mrklas, 
Deuchar, Rowe, 
Leigh, Bhutani, 
& Stickland 
(2017). 
The purpose of 
this systematic 
review was to 
examine the 
efficiency of a 
discharge COPD 
care bundle. 
This meta-
analysis 
systematic 
review 
identified 
studies that 
examined care 
bundles for 
discharged 
patients with 
COPD.  One 
of which 
included 
documenting 
spirometry. 
I A total of 14 
studies were 
examined with 26 
different elements 
of care.  Four 
main trials 
revealed that 
these bundles 
reduced 
readmissions to 
the hospital.  One 
of the strategies 
identified in 
implementing this 
bundle was the 
chart audit and 
feedback. 
These discharge 
bundles led to 
less 
readmissions, 
but not 
necessarily any 
reduced 
mortality or 
improved quality 
of life. 
The meta-
analysis aspect 
is a major 
strength.  
Limitations 
include barriers 
and promotors 
of the bundle, 
which were not 
examined.  
Also, possible 
bias due to a 
lack of 
similarity and 
blinding may 
have been 
present. 
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McClellan, 
Millman, 
Presley, Couzins, 
& Flanders 
(2003). 
 
The aim of this 
study was to 
determine if an 
intervention 
involving chart 
feedback of A1C 
causes more 
frequent 
monitoring. 
A randomized 
trial of 
randomly 
selected 
physicians in 
a southern 
American 
state were 
assigned to 
patients who 
met the 
diabetes 
criteria for the 
study.  The 
patients 
sample were 
about 23,000 
and the 
physicians 
were about 
477 and 123 
counties.  
After 
II Claims-based 
feedback was 
involved in the 
intervention.  
Rates for the 
quality indicators 
increased as well 
as the rate of A1C 
testing from 
13.0% to 16.8%. 
Chart feedback 
and education 
regarding A1C 
levels resulted in 
improved 
treatment for 
diabetic 
Medicare 
patients. 
The strength 
was the 
randomized 
aspect as well 
as the large 
sample size.  
An over or 
underestimation 
may have 
occurred since 
indicators were 
initially 
assigned to the 
patients and 
then the 
providers.  
Another 
limitation is that 
the study 
occurred only 
with rural 
counties in a 
single state. 
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assigning 
patients to 
physicians, 
each county 
was placed in 
alphabetical 
order and 
randomly 
assigned a 
number, 
which was 
used to assign 
to either the 
intervention 
or control 
group. 
Thomas, 
Thomas, 
Stroebel, 
Mcdonald, 
Hanson, 
Naessens, . . . 
Kolars (2007). 
The purpose of 
this study was to 
examine the 
impact an audit, 
feedback, and 
patient reminder 
A total of 78 
subjects were 
included in a 
randomized 
controlled 
trial to which 
39 residents 
II Patients that were 
treated by the 
intervention 
group had an 
improved 
adherence to the 
A1C 
Using a chart 
audit and 
feedback system 
with providers 
improved 
diabetes care 
processes, but 
The RCT aspect 
of this study 
was a strength.  
The incomplete 
participation of 
residents, the 
inability to 
SPIROMETRY AND COPD DIAGNOSIS   
 
69
system had on 
diabetes care. 
received the 
instructions, 
chart audit, 
feedback, and 
letter and 39 
were in the 
control group. 
recommendations 
compared to the 
control group.  
did not 
necessarily 
impact the 
intermediate 
clinical results. 
calculate the 
impact of 
interventional 
components, 
and the inability 
to have binding 
because of the 
intervention 
were all 
limitations with 
the study.  
Guerriero, 
Caminati, Viegi, 
Senna, Cesana, 
& Pomari 
(2015). 
The aim of this 
study was to 
evaluate the 
prevalence of 
COPD in 
Northern Italy 
utilizing the 
GOLD and 
ERS/ATS 
criteria. 
A randomized 
cross-
sectional 
study sent 
5,000 
invitation 
letters and 
1,236 subjects 
were included 
based on reply 
and ability to 
perform 
II Pulmonary 
symptoms were 
experienced daily 
by 26.7% and 
only 30.7% had 
previously 
received 
spirometry.  The 
COPD prevalence 
depended on the 
criteria utilized: 
11.7% with the 
Based on the 
prevalence of 
patients with 
COPD, an 
underdiagnosis/
misdiagnosis of 
COPD occurs if 
underutilizing 
spirometry.  This 
may affect 
quality of life 
and fiscal   
The random 
aspect of this 
study is one 
main strength as 
well as the 
population size. 
Also, the study 
utilized 
different 
criterion, which 
is more 
thorough.  One 
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spirometry.  
Spirometry 
and physician 
assessment 
were 
completed 
GOLD criteria, 
9.1% LLN, and 
6.8% physician 
diagnosis.  Of the 
subjects 
previously 
diagnosed, 48.8% 
never received 
spirometry. 
means that may 
be preventable if 
spirometry was 
utilized. 
limitation is that 
the prevalence 
is confined to 
one specific 
area, which 
could limit the 
generalizability. 
Chapman, 
Tashkin, & Pye 
(2001). 
The objective of 
the study was to 
examine if 
gender bias 
affected the 
diagnosis of 
COPD. 
A random 
sample of 192 
primary care 
physicians 
completed a 
hypothetical 
case study and 
follow-up 
interview. 
III A hypothetical 
case study and 
interview was 
provided to the 
PCP’s and the 
outcome revealed 
that COPD was a 
more likely 
diagnosis to be 
given to a male 
by 16%. 
Primary care 
physicians 
underdiagnose 
COPD, 
especially with 
their female 
patients.  
Spirometry is 
underused and 
may ultimately 
reduce COPD 
The random 
sampling 
method of 
choosing 
physicians was 
a strength.  A 
limitation 
included the 
lack of studying 
real encounters 
with patients 
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underdiagnosis 
as well as gender 
bias. 
and the 
physicians 
background/trai
ning was not 
examined. 
Walters, Walters, 
Nelson, 
Robinson, Scott, 
Turner, & 
Wood-Baker 
(2011). 
The purpose of 
this study was to 
quantify the 
number of 
patients with 
COPD who were 
misclassified in 
primary care and 
to identify the 
causes correlated 
with the 
misdiagnoses. 
A cross-
sectional 
study was 
completed in 
31 different 
practices in 
Australia.  A 
total of 341 
patients were 
eligible for 
the study 
based on their 
COPD 
diagnosis or 
prescription 
for 
Tiotropium. 
III The subjects were 
given spirometry 
and the results 
concluded that of 
the 341 patients 
with a COPD 
diagnosis/Tiotropi
um usage, 107 
were 
misclassified.  
Misclassification 
was shown to be 
increased with 
overweight/obese 
patients and those 
that have reported 
allergic rhinitis. 
Basing a COPD 
diagnosis on 
symptoms in 
primary care 
may be 
inaccurate, 
especially with 
overweight 
patients.  The 
study highlighted 
the importance 
of utilizing 
spirometry to 
prevent improper 
management. 
One strength of 
this study was 
that the 
intervention 
occurred across 
many different 
practices.  A 
main limitation 
was that the 
study examined 
patients with 
COPD in 
primary care 
and not an 
ambulatory 
setting. 
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Jain, Allison, 
Andrews, Mejia, 
Mills, & 
Peterson (2015). 
The purpose of 
this study was to 
examine the 
misdiagnosis of 
asthma/COPD 
and its factors in 
frequent 
exacerbators. 
A 
retrospective 
chart review 
with total of 
333 patients 
were enrolled 
in the study 
based on 
inclusion and 
exclusion 
criteria.  
Patients 
received 
various 
diagnostic 
testing and 
two 
pulmonologist
s made the 
final 
diagnoses. 
IV Of the total 333 
subjects who are 
considered to be 
frequent 
exacerbators, 
misdiagnosis was 
identified in 26% 
of patients.  Risk 
factors for 
misdiagnosis 
include 
underusing 
spirometry and 
smoking pack 
years. 
Objective 
confirmation is 
necessary to 
avoid 
misdiagnosis of 
frequent 
asthma/COPD 
exacerbations.  
Employing 
spirometry is 
helpful is 
reducing 
misdiagnoses. 
The 
retrospective 
chart study is 
the main 
limitation.  
Also, post-
bronchodilator 
spirometry was 
not done in 
about 15% of 
patients and 
may have 
skewed the 
results.  The 
strength of this 
study was its 
incorporation of 
frequent 
exacerbators. 
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Gershon, Hwee, 
Croxford, Aaron, 
& To (2014). 
This study 
examined the 
correlation of 
patient and 
physician factors 
with ordering 
spirometry to 
confirm the 
diagnosis of 
COPD. 
A chart 
review 
population 
study 
examined 
491,754 
patients that 
were 35 years 
of age and 
older and 
newly 
diagnosed 
with COPD 
between 2000 
and 2010.   
IV Only 35.9% of 
the patients newly 
diagnosed with 
COPD had 
spirometry 
completed.  
Only about one-
third of patients 
newly diagnosed 
with COPD 
received 
spirometry. The 
age, various co-
morbidities, and 
specific 
physician factors 
have been shown 
to impact the use 
of spirometry. 
The strength of 
this study is the 
large population 
size.  
Limitations 
include the lack 
of certainty of 
when the 
spirometry was 
completed as 
well as a lack of 
indication if the 
spirometry was 
diagnostic in 
nature. 
Gershon, 
Mecredy, 
Croxford, To, 
Stanbrook, & 
Aaron (2017). 
The purpose of 
this study was to 
determine if 
completing 
spirometry to 
confirm a COPD 
diagnosis was 
correlated with 
A longitudinal 
population 
study between 
2005 and 
2012 included 
68,898 
patients who 
had COPD 
IV Patients with 
COPD who 
received 
spirometry had a 
9% lower risk of 
mortality and 
hospital 
Confirming the 
diagnoses of 
COPD utilizing 
spirometry is 
correlated with a 
decreased risk of 
mortality as well 
as admissions to 
A strength to 
this study was 
the large 
population size, 
but limitations 
include 
misclassificatio
n, bias, and 
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improved health 
outcomes. 
and were 
older than 42 
years old. 
admission rate for 
COPD. 
the hospital for 
COPD. 
confounding 
factors.  Also, 
an association 
between 
spirometry and 
patient 
outcomes may 
not necessarily 
indicate 
causation. 
Wu, Wise, 
Medinger, 
(2017). 
The purpose of 
this study was to 
examine the 
frequency that 
patients are 
discharged with 
a COPD 
diagnosis that 
was confirmed 
by spirometry at 
the Veterans 
Affairs (VA) 
system. 
A 
retrospective 
longitudinal 
study between 
2005 and 
2015 
examined 826 
patients 
hospitalized 
for COPD at 
the VA. 
IV Of the 826 
subjects, 21% 
never had 
spirometry 
completed and 
only 56% had 
obstruction 
identified through 
spirometry. 
Without 
spirometric 
confirmation of 
COPD, issues 
with 
hospitalizations, 
readmissions, 
quality of care, 
and resource 
waste will be 
negatively 
impacted. 
One specific 
limitation is that 
of the 826 
patients, 12% of 
the patients who 
received the 
spirometry were 
unable to 
complete the 
breathing 
maneuvers 
accurately. 
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Mapel, Dalal, 
Johnson, Becker, 
& Hunter (2015). 
The purpose of 
this study was to 
examine primary 
care physicians’ 
impressions of 
the severity level 
of their patients 
with COPD.  
The study also 
attempted to 
examine if 
spirometry 
results impacted 
the physicians’ 
viewpoint and 
treatment 
choices. 
A 
randomized, 
multicenter, 
cross-
sectional, 
observational 
study 
recruited 899 
patients with 
COPD in 89 
practices. 
IV The subjects 
received a 
questionnaire and 
spirometry.  The 
primary care 
physicians 
completed a 
questionnaire and 
case study forms.  
The physician’s 
impressions of 
severity for their 
patients were only 
30% accurate 
with 41% of the 
severities being 
underestimated.  
About 30% of 
patients received 
a change in their 
severity after 
spirometry, and 
37% of treatments 
The study 
concluded that 
without 
spirometry, 
underestimations 
of COPD 
severity occur.  
Also, about one-
third of these 
patients with 
COPD received 
treatment 
changes after 
they received 
spirometry.  
Therefore, 
spirometry is a 
helpful tool in 
primary care for 
diagnosing and 
accurately 
treating COPD. 
The strength of 
this study was 
that the design 
as randomized 
multicenter.  
The limitations 
of this study 
include it being 
observational 
and recruiting 
physician’s with 
a previous 
interest in 
COPD and 
experience 
treating COPD.  
Also, the 
terminology of 
the severity of 
COPD is 
considered 
subjective in 
nature, which 
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were changed by 
physicians based 
on the severity 
levels. 
may have 
skewed the 
results. 
Fortis, Corazalla, 
Jacobs, & Hyun  
(2016). 
The purpose of 
this study was to 
determine the 
number of 
people who 
receive a 
persistent 
empirical COPD 
diagnosis and 
treatment as well 
as identify 
factors that 
contributed to 
the empiric 
diagnosis and 
treatment of 
COPD despite 
spirometry and 
A 
retrospective 
chart review 
ensued 
including 
1,805 subjects 
with 
Spirometry. 
IV About 7% of 
these patients had 
an empiric COPD 
diagnosis and 
24% had an 
empiric treatment.   
Persistent COPD 
empiric 
diagnosis and 
treatment still 
occurs despite 
spirometry 
results indicating 
no obstruction. 
Limitations 
include the 
retrospective 
aspect as well 
as being 
operated in only 
one healthcare 
system.  Despite 
the limitations, 
the 
overdiagnosis 
and 
overtreatment 
of COPD needs 
to be further 
evaluated and 
managed. 
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lung volume 
measurements. 
Asche, Leader, 
Plauschinat, 
Raparla, Yan, & 
Young (2012). 
The purpose of 
this study was to 
measure the 
potential fiscal 
savings for 
adhering to 
GOLD standards 
to treat COPD. 
An 
observational, 
retrospective, 
cohort study 
ensued with 
761 subjects 
who were 
chosen based 
on inclusion 
criteria. 
IV Adhering to the 
GOLD standards 
showed an 
average fiscal 
savings of $5,889 
for LAMA + 
LABA treatment 
group, $3,330 for 
LABA + ICS 
group, and 
$10,217 for 
LAMA + LABA 
ICS group. 
Staging of 
COPD utilizing 
spirometry and 
adhering to the 
GOLD standards 
was correlated 
with more fiscal 
savings with 
moderate to 
severe staged 
COPD.  
Appropriately 
prescribing 
inhalers impacts 
not only clinical, 
but also fiscal 
responsibility. 
Measuring the 
fiscal aspect of 
this study was a 
strength.  The 
main limitations 
include possible 
discrepancies 
with gathering 
information 
from the EMR.  
Therefore, the 
true cost of 
treatment may 
be higher than 
reported.  
Secondly, the 
inclusion/exclus
ion criteria 
resulted in a 
relatively small 
SPIROMETRY AND COPD DIAGNOSIS   
 
78
number of 
subjects. 
Spero, Bayasi, 
Beaudry, Barber, 
& Khorfan 
(2017). 
The purpose of 
this study was to 
examine the 
prevalence of 
spirometry usage 
and to assess the 
accuracy of the 
diagnosis of 
patients 
hospitalized for 
COPD. 
A total of 
6,018 patients 
were 
examined 
through a 
retrospective 
chart based on 
their age 
being greater 
than 18 and 
having a 
COPD 
IV Spirometry 
confirmed the 
COPD diagnosis 
for 69.2% of 
patients.  
Restrictive lung 
disease was 
identified in 
26.6% and 4.2% 
were normal.  
Factors correlated 
with obstruction 
Up to one-third 
of patients 
admitted with 
COPD to the 
hospital may be 
misdiagnosed 
based on 
spirometry 
results.  Factors 
correlated with 
misdiagnosing 
COPD include 
The main 
limitation of 
this study was 
that it was 
conducted in 
one center and 
it was 
retrospective in 
nature.  The 
main strength of 
this study was 
that it was 
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diagnosis.  Of 
these patients, 
a total of 390 
had adequate 
spirometry 
based on 
ATS-ERS 
criteria.  
Other data of 
the patients 
were collected 
including 
their smoking 
status and 
BMI. 
include smoking 
status as well as 
an elevated pack-
year history.  
Patient factors 
correlated with 
misdiagnosing 
COPD include an 
elevated BMI and 
other co-
morbidities. 
an elevated BMI, 
other co-
morbidities, and 
a lower pack-
year smoking 
history. 
conducted with 
real-world 
situations in a 
local 
community 
teaching 
hospital. 
Walker, 
Mitchell, 
Diamantea, 
Warburton, & 
Davies (2006). 
The purpose of 
this study was to 
examine if 
spirometry usage 
in primary care 
to diagnose 
COPD would 
A 
retrospective 
review 
examined a 
total of 1,508 
subjects who 
were referred 
for open-
IV Of the 1,508 
patients referred, 
130 received a 
new diagnosis, 
most of which 
was COPD.  
These patients 
with COPD were 
Spirometry 
increases the rate 
of COPD 
diagnosis and 
also results in 
improved 
treatment. 
Limitations 
include its 
retrospective 
review.  An 
important 
strength was the 
random 
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improve 
management. 
access 
spirometry.  
Exclusions for 
referral 
include <40 
years of age 
and no history 
of smoking. 
found to be 
undertreated and 
spirometry 
resulted in an 
increase in using 
pharmacologic 
treatment for 
these patients. 
selection of 
practices. 
Casas Herrera, 
Montes de Oca, 
López Varela, 
Aguirre, Schiavi, 
& Jardim (2016). 
The aim of this 
study was to 
examine COPD 
under/misdiagno
sis rates in 
primary care.  
Also, the aim 
was to determine 
factors correlated 
with COPD 
underdiagnosis. 
This 
multicenter, 
international 
study was 
conducted in 
Latin 
America, in 
which 
subjects were 
included in 
the study if 
they were >40 
years and at 
risk for 
COPD.  A 
IV Spirometry was 
initiated with 
these patients and 
the results 
examined.  COPD 
underdiagnosis 
was 65.8% and 
misdiagnosis was 
26.4%. 
COPD 
underdiagnosis is 
a major issue in 
primary care.  
Spirometry 
usage should be 
encouraged and 
available to 
primary care 
patients to 
reduce 
underdiagnosis. 
Limitations 
include the 
possible 
overestimation 
of COPD 
underdiagnosis 
in the study.  
Also, the results 
obtained may 
not pertain to all 
countries in 
Latin America.  
However, one 
particular 
strength is its 
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total of 1,540 
subjects were 
included in 
the study. 
international 
aspect. 
Ghattas, Dai, 
Gemmel, & 
Awad (2013). 
The purpose of 
this study was to 
identify the 
patients that are 
over diagnosed 
with COPD and 
subsequently 
mistreated. 
A 
retrospective 
descriptive 
cohort study 
examined 80 
patients who 
were 
previously 
diagnosed 
with COPD or 
prescribed an 
anticholinergi
c inhaler 
without a 
COPD 
diagnosis. 
Patients were 
referred for 
spirometry to 
IV Of the 80 
subjects, 
spirometry 
showed 42.5% 
had no 
obstruction, 
22.5% had a 
reversible 
obstruction, and 
35% had non-
reversible 
obstruction. 
Without 
spirometry, 
COPD 
overdiagnosis 
occurs at a high 
rate.  Confirming 
a COPD 
diagnosis with 
spirometry is 
necessary to 
prevent 
mistreatment, 
prevent using 
incorrect 
medications with 
possible side 
effects, and 
avoid 
unnecessary 
Some 
limitations 
include patient 
recall bias, data 
input error, and 
the low number 
of subjects.  
One main 
strength is that 
the spirometry 
was completed 
based on 
recommendatio
ns of the 
American 
Thoracic 
Society. 
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confirm their 
COPD 
diagnosis or 
assess 
severity of 
diagnosis. 
costs, especially 
in populations 
with fewer 
health resources. 
Jagana, Bartter, 
& Joshi (2015). 
The purpose of 
this article was 
to identify the 
causes and 
solutions for the 
delay in COPD 
diagnosis. 
This article 
examined 
several 
studies and 
literature 
regarding 
COPD 
diagnosis 
delays. 
V Ironically, COPD 
is both under and 
over diagnosed. 
The early 
diagnosis of 
COPD needs to 
be examined 
further and 
requires a culture 
change in 
primary care.  
Respiratory 
symptoms in a 
smoker over the 
age of 40 should 
be emphasized in 
that they need 
spirometric 
evaluation. 
Its limitation is 
that it is only a 
level V 
evidence, but 
one strength is 
that it examined 
multiple studies 
to make 
conclusions 
about COPD 
and its 
diagnosis delay. 
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